ASTROTECH Corp Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
ASTROTECH Corp (ASTC) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-20.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-09-20
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $0.00.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $0.00.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-03-31 was $0.00.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $223.00K.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ASTROTECH Corp right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $246.00K, a 84.70% decline from fiscal 2020.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 10-K · filed 2024-09-20 | |||
| 2023-12-31 | $0.00 10-Q · filed 2024-02-13 | |||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $0.00 derived: sum of 2 quarters · filed 2024-09-20 | $223.00K 10-K · filed 2024-09-20 | |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $223.00K 10-Q · filed 2023-05-12 | ||
| 2022-12-31 | $223.00K 10-Q · filed 2024-02-13 | |||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $0.00 derived: sum of 2 quarters · filed 2023-09-28 | $0.00 derived: sum of 3 quarters · filed 2023-09-28 | $0.00 10-K · filed 2023-09-28 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 10-Q · filed 2023-05-12 | $246.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-13 | $0.00 10-Q · filed 2023-02-13 | $246.00K derived: sum of 3 quarters · filed 2023-02-13 | $246.00K derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | $246.00K derived: sum of 2 quarters · filed 2022-09-15 | $246.00K derived: sum of 3 quarters · filed 2022-09-15 | $246.00K derived: sum of 4 quarters · filed 2022-09-15 |
| 2021-06-30 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15 | $246.00K derived: sum of 2 quarters · filed 2022-09-15 | $246.00K derived: sum of 3 quarters · filed 2022-09-15 | $246.00K 10-K · filed 2022-09-15 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | $0.00 derived: sum of 3 quarters · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 derived: sum of 3 quarters · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-21 | $0.00 derived: sum of 2 quarters · filed 2021-09-21 | $0.00 derived: sum of 3 quarters · filed 2021-09-21 | $1.61M 10-K · filed 2021-09-21 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $1.61M 10-Q · filed 2021-05-14 | $1.61M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $1.61M 10-Q · filed 2021-02-16 | $1.61M derived: sum of 3 quarters · filed 2021-02-16 | $1.61M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $1.61M 10-Q · filed 2020-11-13 | $1.61M derived: sum of 2 quarters · filed 2020-11-13 | $1.61M derived: sum of 3 quarters · filed 2020-11-13 | $1.61M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-08 | $0.00 derived: sum of 2 quarters · filed 2020-09-08 | $0.00 derived: sum of 3 quarters · filed 2020-09-08 | $0.00 10-K · filed 2020-09-08 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | $0.00 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |